The general elections 2019 is in its last phase and volatility has been increasing. Despite this, there were stocks that attracted fund managers in the month of April 2019.

Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from the USFDA for the Post marketing Adverse Drug Experience (PADE) inspection, indicating successful closure of the inspection.

L&T Infotech’s wholly-owned subsidiary Syncordis S.A. has announced its strategic global partnership with Temenos, the banking software company.

Following stocks are close to their 52-weeks low as at 2:41 p.m. on May 14, 2019.

PPF is one of the most popular investment options for investors looking for good returns, tax saving and safety of investment. So, how does it fare when compared with debt MFs? Let’s find out.

Glenmark Pharmaceuticals Inc., USA, has been granted final approval by the USFDA for Esomeprazole magnesium delayed-release capsules USP, 20 mg and 40 mg, a generic version of Nexium delayed‐release capsules, 20 mg and 40 mg, of AstraZeneca Pharmaceuticals LP. 

The markets on May 14, 2019 opened flat. BSE Sensex is trading at 37,446.26, up by 355.44 points and the Nifty is trading at 11,253.75, up by 105.55 points. 

SRF Limited has announced that it has entered into a definitive agreement to sell its engineering plastics business to DSM, which is the life sciences and materials sciences company. SRF is a chemical-based multi-business company engaged in the manufacturing of industrial and speciality intermediates.

Overall volumes in futures & options currently stand at 1.07 crore contracts with a turnover of Rs.7,20,742.67 crore.

Overall volumes in futures & options currently stand at 1.07 crore contracts with a turnover of Rs. 7,20,742.67 crore.